Misalignment Is a Silent Killer—And the FDA Is Looking for Cracks
FDA Uncertainty: Why First-Cycle Approval Is Now a Matter of Survival Leadership shake-ups, budget...
read Details
Transport Simulation Testing for Your Therapy: A Better Approach Than Real-World Shipping Tests
Transport Simulation Testing for Your Therapy: A Better Approach Than Real-World Shipping Tests
Modality Solutions has access to the latest regulatory agency requirements for emerging new therapies. Join Modality Solutions principals Gary Hutchinson and Daniel Littlefield, in an informative webinar on successfully integrating transport simulation testing for environmental hazards into your filing strategy.
During this 45-minute pre-recorded webinar, you will take away valuable information on:
- Why accelerated sequential testing alone (e.g., ASTM, ISTA) is no longer acceptable by the FDA for drug product testing.
- Why real-world testing cannot test the worst-case edges of your operating space.
- Why real-world testing in the post-COVID-19 world will be difficult, time-consuming, and expensive.
Receive this webinar to your email
You may also like
In This New Regulatory Landscape, You’re Either Ready—or at Risk
FDA Uncertainty: Why First-Cycle Approval Is Now a Matter of Survival Leadership shake-ups, budget...
read Details
Cell & Gene Therapies Are Under the Microscope—And Few Are Passing
FDA Uncertainty: Why First-Cycle Approval Is Now a Matter of Survival Leadership shake-ups, budget...
read Details